Litcius/Paper detail

Cancer cell membrane-camouflaged MOF nanoparticles for a potent dihydroartemisinin-based hepatocellular carcinoma therapy

Yusha Xiao, Wei Huang, Daoming Zhu, Quanxiong Wang, Baiyang Chen, Zhisu Liu, Yang Wang, Quanyan Liu

2020RSC Advances49 citationsDOIOpen Access PDF

Abstract

and is a highly effective and low-toxicity anti-tumor drug with a strong clinical application value.

Topics & Concepts

DihydroartemisininFerrousChemistryToxicityCancer cellHepatocellular carcinomaIn vivoCancerTumor microenvironmentCancer researchPharmacologyNanotechnologyMaterials scienceMedicineTumor cellsArtemisininInternal medicineImmunologyBiologyMalariaPlasmodium falciparumBiotechnologyOrganic chemistryPeptidase Inhibition and AnalysisCancer Mechanisms and TherapyMXene and MAX Phase Materials
Cancer cell membrane-camouflaged MOF nanoparticles for a potent dihydroartemisinin-based hepatocellular carcinoma therapy | Litcius